Входя на эту страницу, Вы подтверждаете, что являетесь  медицинским работником.

Status message

Not the entire site translated, but only to "Magazine"

Psychotropic Drugs Induced Delirium

D.I. Malin
Federal Medical Research Center for Psychiatry and Narcology by the name of V.P.Serbsky Minzdrava RF

The article reviews domestic and foreign publications on the problem of delirium caused by taking psychotropic drugs. Data on epidemiology, risk factors, etiology and pathogenesis of psychopharmacological delirium are presented, modern approaches to therapy and prevention of complications.

References: 
  • 1. Liston E.H. Delirium in the aged // Psychiatr Clin North Am. – 1982. –Vol. 5 (I). – P. 49–66.
  • 2. Carter G., Dawson A. and Lopert R. Drug-Induced Delirium (incidence, management and prevention) // Drug Safety. – 1996. – Oct. – Vol. 15 (4). –P. 291–301.
  • 3. Churkin A.A., Martyushov A.N. Prakticheskoe rukovodstvo po ispol'zovaniyu MKB-10 v psihiatrii i narkologii. – M., 2004. – 137 s.
  • 4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. – Washington, DC: American Psychiatric Association, 2012–2013. – 947 r.
  • 5. Avruckij G.Ya., Gurovich I.Ya., Gromova V.V. Farmakoterapiya psihicheskih zabolevanij. – M.: Medicina, 1974. – 470 s.
  • 6. Mosolov S.N. Osnovy psihofarmakoterapii. – M.: Vostok, 1996. – 288 s.
  • 7. Cieslak G. Komplikationen der Reserpinbehandlung // Nervenarzt. – 1960. – Vol. 31, No. 3. – P. 102–109.
  • 8. Helmchen H. Delirante Ablaufeunterpsychiatrischer Pharmakotherapie // Archivf Psych Neurol. –1961. – Vol. 202. – P. 395–411.
  • 9. Lai G. Manifestatiousconfuso-oniriques an cours du traitement aux thymoleptiques // Schweizeirische Med. Wocheuschrift. – 1961. – Vol. 91, No. 34. – P. 1002–1005.
  • 10. Morozova T.N. Lechenie depressij imizinom (tofranilom) // Zhurnal nevropatologii i psihiatrii imeni S.S. Korsakova. – 1961. – № 2. – S. 176–182.
  • 11. Stolyarov G.V. Lekarstvennye psihozy i psihomimeticheskie sredstva. – M., 1964. – 205 s.
  • 12. Gurovich I.Ya. Pobochnye effekty i oslozhneniya pri nejrolepticheskoj terapii. Diss. ... d-ra med. nauk. – M., 1971. –443 s.
  • 13. Mazur M.A., Mazur A.S., Tatarenko A.M., Bochenkova Ya. K. Delirioznoe pomrachenie soznaniya kak oslozhnenie aminazinoterapii u detej // Voprosy psihofarmakologii. M., 1967. S. 319–322.
  • 14. Mamceva V.N., Semenovskaya E.I. Toksicheskij delirij pri lechenii nejroleptikami detej s nervno-psihicheskimi zabolevaniyami // Zhurnal nevropatologii i psihiatrii imeni S.S. Korsakova. – 1968. – № 10. – S. 1566–1570.
  • 15. Karisson I. Drugs That Induce Delirium. Dement // Geriatr Cogn Disord. – 1999. – No. 10. – P. 412–415.
  • 16. Alagiakrishnan K., Wiens C.A. An approach to drug induced delirium in elderly // Postgrad Med J. – 2004. – Vol. 80. – P. 388–393.
  • 17. Kogo A. Selective serotonin reuptake inhibitors-induced delirium: A case review // Psychiatria Danubina. – 2014. – Vol. 26, No. 3. – P. 277–280.
  • 18. Rosen J, etal. Psychiatric admissions due to adverse drug reactions // Compr Psychiatry. – 1989. – Vol. 30 (6). – P. 534–539.
  • 19. Danielczyk W., Pohon S., Gershon S. Antipsychotics in the elderly // Acta Psychiatr Scand. – 1990. – Vol. 82 (suppl. 358). – P. 170–175.
  • 20. Preskorn S.H., Jerkovich G.S. Central nervous system toxicity of tricyclic antidepressants: Phenomenology, course, risk factors and role of therapeutic drug monitoring // J ClinPsychopharmacol. – 1990. –Vol. 10. – P. 88–95.
  • 21. Brown A.S., Rosen J. Lithium-induced delirium with therapeutic serum lithium levels: A case report // J Geriatr Psychiatry Neurol. – 1992. – Vol. 5. – P. 53–55.
  • 22. Aldred D.P. Avoid benzodiazepines and opioids in people at risk of delirium // Evidence-Based Nursing. – 2011. – Jul. –Vol. 14 (3). – P. 75–76.
  • 23. Mosolov S.N. Oslozhneniya pri sochetannom primenenii solej litiya s nejroleptikami u bol'nyh endogennymi psihozami // Zhurnal nevropatologii i psihiatrii imeni S.S. Korsakova. – 1983. – T. 83, № 3. – S. 115–121.
  • 24. Mosolov S.N. Klinicheskoe primenenie sovremennyh antidepressantov. – SPb.: Medicinskoe informacionnoe agentstvo, 1995. – 568 s.
  • 25. WolfB. etal. Psychiatric admissions due to adverse drug reactions // Compr Psychiatry. – 1989. – Vol. 30 (6). – P. 534–545.
  • 26. Lipowski Z.J. Delirium: acute confusional states. – New York: Oxford University Press, 1990. – P. 229–276.
  • 27. Gunther M.L., Morandi A., Ely W.L. Patophysiology of delirium in ICU // Crit Care Clin. – 2008. –Vol. 24, No. 1. – P. 290–298.
  • 28. Golinger R.C., Peet L., Tune L.E. Association of elevated plasma anticholinergic activity with delirium in surgical patient // Am J Psychiatry. – 1987. –Vol. 144. – P. 1218–1220.
  • 29. Gel'fand B.R., Linev D.V., Yarosheckij A.I. Ivahnik D.I. Delirij u pacientov v kriticheskih sostoyaniyah // Ostrye psihicheskie rasstrojstva v intensivnoj terapii / pod. red. B.R. Gel'fanda, V.N. Krasnova. – M., 2014. – S. 47–85.
  • 30. Fong T.G. Cerebral perfusion changes in older delirious patients using 99mTcHMPAO SPECT. J. Gerontology. Series A // Biological Sciences and Medical Sciences. – 2006. – Vol. 61. – P. 1294–1299.
  • 31. Yokota H. et al. Regional cerebral blood flow in delirium patients // Psychiatry Clin Neurosci. – 2003. –Vol. 57. – P. 337–339.
  • 32. Van den Bogart S. et al. Biomarkers associated with delirium in critically ill patients and their relation with long-term subjective cognitive dysfunction; indications for different pathways governing delirium in inflamed and noninflamed patients // Crit Care. – 2011. – Vol. 15. – P. 297.
  • 33. Malin D.I. Pobochnoe dejstvie psihotropnyh sredstv. – M.: Vuzovskaya kniga, 2000. – 208 s.
  • 34. Malin D.I., Ravilov R.S. Rasprostranennost', klinika, diagnostika i terapiya tyazhelyh oslozhnenij nejrolepticheskoj terapii // Social'naya i klinicheskaya psihiatriya. – 2014. – № 4. – S. 90–98.
  • 35. Neznanov N.G., Mosolov S.N., Ivanov M.V. Psihofarmakoterapiya // Psihiatriya: Nacional'noe rukovodstvo / pod red. N.G. Neznanova, Yu.A. Aleksandrovskogo. – M., 2018. – S. 820–893.
  • 36. Inouye S.K. redisposing and precipitating factors for delirium in hospitalized older patients // Dement Geriatr Cogn Disord. – 1999. – No. 1. – P. 393–400.
  • 37. Inouye S.K. et all. Delirium in older person // N Engl J Med. – 2006. – Vol. 354. – P. 1157–1165.
  • 38. Savina M.A. Lechenie i profilaktika postinsul'tnogo deliriya // Sovremennaya terapiya v psihiatrii i nevrologii. – 2015. – № 4. – S. 4–8.
  • 39. Seitz D.P., Gill S.S., Van Zyl L.T. Antipsychotics in the treatment of delirium: a systematic review // J Clin Psychiatry. – 2007. – Vol. 68. – P. 11–21.
  • 40. Platt M.M. et al. Efficacy of neuroleptics for hypoactive delirium // J Neuropsychiatry Clin. Neurosci. – 1994. –Vol. 6. – P. 66–67.
  • 41. Breitbart W. et al. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients // Am J Psychiatry. – 1996. – Vol. 15. – P. 231–237.
  • 42. Skrobik Y. et all. Olanzapine vs Haloperidol: treating delirium in a critical care setting Intensiv // Care Med. – 2004. – Vol. 30. – P. 444–449.
  • 43. Hu H. et all. Olanzapine and haloperidol for senile delirium: a randomized controlled observation // Chin J Clin Rehab. – 2006. –Vol. 10. – P. 188–190.
  • 44. Han C.S., Kim Y.K. A double-blind trial of risperidone and haloperidol for the treatment of delirium // Psychosomatics. – 2004. –Vol. 45. – P. 297–301.
  • 45. Wang H., Woo Y., Bahk W. Atypical antipsychotics in the treatment of delirium // Psychiatry Clin Neurosci. –2013. – Vol. 6, No. 5. – P. 323–331.
  • 46. Maneeton B. et all. Quetiapine versus haloperidol in the treatment of delirium: a double-blind, randomized, controlled trial // Drug Des Devel Ther. – 2013. – No. 7. – P. 657–667.
  • 47. Gehlbach B.K., Kress J.P. Sedation in the intensive care unit // Current Opinion in Critical Care. – 2002. – Vol. 8. – P. 290–298.
  • 48. Bourne R.S., Mills G.H. Sleep disruption in critically ill patient – pharmacological considerations // Anesthesia. – 2004. – Vol. 153. – P. 231–237.
  • 49. Lonergran E. et all. At this time, benzodiazepines cannot be recommend for the treatment of nonalcochol related delirium. Cohrane Summaries. Published Online: October 7.2009. – URL: www.Cochrane.org (accessed 12/052018).
  • 50. Fong T., Tubelaev S., Inouye K. Deislirium in elderly adults: diagnosis, prevention and treatment // Nat Rev Neurol. – 2009. – Vol. 5, No. 4. – P. 210–220.
  • 51. Cervera C. et all. Delirium in the elderly: A systematic review of pharmacological and nonfarmacological treatments // Dement Neuropsycol. – 2017. – Jul–Sept. – Vol. 11, No. 3. – P. 270–275.
  • 52. Liptzin B. et all. Donepezil in the prevention and treatment of post-surgical delirium // Am JGeriatr. Psychiatry. – 2005. – Vol. 13. – P. 1100–1106.
  • 53. Sampson E.L. et al. A randomized, double-blind, placebo-controlled trial of donepezil hydrochloride (Aricept) for reducing the incidence of postoperative delirium after elective total hip replacement // Int J Geriatr Psychiatry. – 2007. – Vol. 22. – P. 343–349.
  • 54. Chakraborty D., Tampi D., Tampi R. Melatonin and Melatonin Agonist for Delirium in the Elderly Patients // Am J Alzhtimers Dis Other Demen. – 2015. – Vol. 30, No. 2. – P. 119–129.
  • 55. Sultan S. Assessment of role of preoperative melatonin in prevention and treatment of postoperative delirium after hip arthroplasty under spinal anesthesia in elderly // Saudi J Anaesth. – 2010. – No. 4. – P. 169–173.